Skip directly to Accessibility Notice

How to Purchase

PPH
VanEck Vectors Pharmaceutical ETF

Fund Description

VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

 
 

  • Fund Ticker

    PPH
  • Exchange

    NASDAQ
  • Commencement

    12/20/2011
  • ETF Structure

    Physical
  • Administrator

    Van Eck Associates
  • Custodian

    Bank of New York Mellon
  • Index Ticker

    MVPPHTR
  • Index Rebalancing

    Quarterly

 
as of 10/16/19

  • 30-Day SEC Yield1

    1.54%
  • Total Net Assets

    $181.8M
  • Number of Holdings

    25
  • Options

    Available
  • Gross Expense Ratio2

    0.43%
  • Net Expense Ratio/TER2

    0.36%
  • Distribution Frequency

    Quarterly
  • Next Distribution Date

    12/27/2019

Key Points

Highly Liquid Companies 
Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
Industry Leaders
Index methodology favors the largest companies in the industry
Global Scope 
Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation
 

Trading Information

  • Fund Ticker

    PPH
  • Index Total Return Ticker

    MVPPHTR
  • NAV

    PPHNV
  • Intraday NAV (IIV)4

    PPHIV
  • Shares Outstanding

    3,188,138
  • Estimated Cash

    PPHEU
  • Total Cash

    PPHTC
  • CUSIP

    92189F692
  • ISIN

    US92189F6925
Source: Bloomberg

Fees and Expenses2

  • Management Fee

    0.35%
  • Other Expenses

    0.08%
  • Gross Expense Ratio

    0.43%
  • Fee Waivers and
    Expense Reimbursement

    -0.07%
  • Net Expense Ratio/TER2

    0.36%
2Expenses for PPH are capped contractually at 0.35% until February 1, 2020. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Prices as of 10/16/19

NAV/
Last Price
Volume
30-Day Avg./
Last Trading Day
Daily Change
NAV/
Last Price
YTD Change
NAV/
Last Price
Premium/
Discount
Prem/Discount
Distribution Charts
NAV &
Prem/Discount
History
NAV
Chart
PPH $57.01
$57.05
88,721
18,930
$0.22 / +0.39%
$0.31 / +0.55%
+5.74%
+6.25%
$0.04
0.07%

Performance History: Average Annual Total Returns* (%)

1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.99 -2.56 5.04 -9.88 1.59 -0.25 -- 8.34
PPH (Share Price) 0.99 -2.40 5.59 -9.77 1.62 -0.24 -- 8.49
MVPPHTR (Index) 1.01 -2.63 4.49 -10.02 1.56 -0.25 -- 8.29
Performance Differential (NAV - Index) -0.02 0.07 0.55 0.14 0.03 0.00 -- 0.05
1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.99 -2.56 5.04 -9.88 1.59 -0.25 -- 8.34
PPH (Share Price) 0.99 -2.40 5.59 -9.77 1.62 -0.24 -- 8.49
MVPPHTR (Index) 1.01 -2.63 4.49 -10.02 1.56 -0.25 -- 8.29
Performance Differential (NAV - Index) -0.02 0.07 0.55 0.14 0.03 0.00 -- 0.05

Top 10 Holdings (%) as of 09/30/19 Daily Holdings

Total Holdings: 25
Swipe
to view
full data
Holding Name
Ticker
Shares Market Value
(US$)
% of Net
Assets
Abbvie Inc
ABBV US
103,767
7,857,237 5.55
Sanofi
SNY US
165,650
7,674,565 5.42
Glaxosmithkline Plc
GSK US
176,649
7,539,379 5.32
Astrazeneca Plc
AZN US
167,302
7,456,650 5.26
Novo Nordisk A/S
NVO US
141,833
7,332,766 5.18
Merck & Co Inc
MRK US
86,960
7,320,293 5.17
Eli Lilly & Co
LLY US
64,560
7,219,745 5.10
Johnson & Johnson
JNJ US
54,972
7,112,277 5.02
Novartis Ag
NVS US
81,129
7,050,110 4.98
Pfizer Inc
PFE US
192,749
6,925,472 4.89
Top 10 Total (%) 51.89
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 09/30/19

  • Country

    % of Net Assets
  • United States

    61.77
  • United Kingdom

    12.05
  • France

    5.42
  • Denmark

    5.18
  • Switzerland

    4.98
  • Japan

    4.53
  • Israel

    3.29
  • Ireland

    2.49
  • Other/Cash

    0.30

Sector Weightings (%) as of 09/30/19

  • Sector

    % of Net Assets
  • Health Care

    99.7
  • Other/Cash

    0.3